Ultrasound appearance of thyroid tissue in hypothyroid infants

Area of Science:

• Pediatric Endocrinology
• Neonatal Screening
• Thyroid Disorders

Background:

• Congenital hypothyroidism (CH) requires timely levothyroxine (l-T4) treatment.
• Optimizing the initial l-T4 dose is crucial for early normalization of thyroid-stimulating hormone (TSH).
• Infant thyroid gland location (eutopic vs. noneutopic) may influence treatment response.

Purpose of the Study:

• To identify factors predicting the need for a higher starting dose of levothyroxine (l-T4) in infants with CH.
• To assess the utility of ultrasonography (US) in guiding initial l-T4 dosing for TSH normalization.

Main Methods:

• Retrospective analysis of 22 hypothyroid infants treated with l-T4 (8-12 microg/kg/day).
• TSH levels were measured at 1-3 weeks and 3-5 weeks post-therapy.
• Infants were evaluated based on US findings (thyroid location), distal femoral epiphysis (DFE) size, and initial thyroid function.

Main Results:

• Infants with noneutopic thyroid or small DFE had significantly higher post-treatment TSH levels.
• Noneutopic thyroid was associated with delayed TSH normalization (8/9 infants normalized after 3 weeks).
• US-determined thyroid location was a significant independent predictor of early TSH normalization (1-3 weeks).

Conclusions:

• Ultrasonography to identify thyroid location (eutopic vs. noneutopic) is valuable for determining appropriate starting l-T4 doses.
• This approach aids in achieving early TSH normalization in infants with CH.
• US findings can guide individualized l-T4 therapy initiation.